MARÍA CRISTINA
PASCUAL IZQUIERDO
Profesora asociada de Ciencias de la Salud
Hospital Universitario La Fe
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Fe (13)
2023
-
An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpura
Expert Review of Hematology, Vol. 16, Núm. 1, pp. 17-32
-
Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry (REPTT)
British Journal of Haematology, Vol. 203, Núm. 5, pp. 860-871
-
Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)
Journal of Clinical Medicine, Vol. 12, Núm. 20
-
Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group
Infectious Diseases and Therapy, Vol. 12, Núm. 2, pp. 303-315
2022
-
Recommendations for the diagnosis and treatment of patients with thrombotic thrombocytopenic purpura
Medicina Clinica, Vol. 158, Núm. 12, pp. 630.e1-630.e14
2021
-
Best practices and recommendations for drug regimens and plasma exchange for immune thrombotic thrombocytopenic purpura
Expert Review of Hematology, Vol. 14, Núm. 8, pp. 707-719
-
Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura
Journal of Clinical Apheresis, Vol. 36, Núm. 4, pp. 563-573
-
Multicentric evaluation of the new HemosIL Acustar® chemiluminescence ADAMTS13 activity assay
International Journal of Laboratory Hematology, Vol. 43, Núm. 3, pp. 485-493
2020
-
Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia
European Journal of Haematology, Vol. 104, Núm. 3, pp. 259-270
2016
-
Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience
Bone Marrow Transplantation, Vol. 51, Núm. 10, pp. 1307-1312
-
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice
European Journal of Haematology, Vol. 97, Núm. 3, pp. 297-302
2015
-
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia
American Journal of Hematology, Vol. 90, Núm. 3, pp. E40-E43
-
Use of eltrombopag after romiplostim in primary immune thrombocytopenia
British Journal of Haematology, Vol. 169, Núm. 1, pp. 111-116